Somerset Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOMERSET
SOMERSET has one hundred approved drugs.
Summary for Somerset
| US Patents: | 0 |
| Tradenames: | 84 |
| Ingredients: | 82 |
| NDAs: | 100 |
| Patent Litigation for Somerset: | See patent lawsuits for Somerset |
Drugs and US Patents for Somerset
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 215969-001 | Jul 3, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | ELTROMBOPAG OLAMINE | eltrombopag olamine | TABLET;ORAL | 219638-001 | Jan 14, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Therap | PRUCALOPRIDE SUCCINATE | prucalopride succinate | TABLET;ORAL | 219078-002 | Jun 24, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | CABERGOLINE | cabergoline | TABLET;ORAL | 218109-001 | Sep 9, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | BUPRENORPHINE HYDROCHLORIDE | buprenorphine hydrochloride | INJECTABLE;INJECTION | 219302-001 | Jan 30, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | TOBRAMYCIN | tobramycin | SOLUTION/DROPS;OPHTHALMIC | 207444-001 | Jun 28, 2017 | AT | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | NALOXONE HYDROCHLORIDE | naloxone hydrochloride | INJECTABLE;INJECTION | 207634-001 | Jul 26, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Somerset
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | 7,070,808 | ⤷ Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-002 | Feb 27, 2006 | 7,070,808 | ⤷ Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | 7,070,808 | ⤷ Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | 7,150,881 | ⤷ Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | RE34579 | ⤷ Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-003 | Feb 27, 2006 | 7,638,140 | ⤷ Start Trial |
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | RE34579 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
